- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Article Review: Atenolol Importance as a Medication and in Industry | ||
| Journal of University of Anbar for Pure Science | ||
| Article 20, Volume 14, Issue 2, 2020, Pages 47-50 PDF (1.38 M) | ||
| Document Type: Review Paper | ||
| DOI: 10.37652/juaps.2022.172386 | ||
| Authors | ||
| Baneen Salam; Emad Yousif* ; Mohammed H. Al-Mashhadani | ||
| Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq | ||
| Abstract | ||
| Atenolol is used with or without other medications to help patients with hypertension (high blood pressure) by reducing their blood pressure. High blood pressure causes heart attacks, strokes, and kidney failure. Moreover, atenolol is also utilized to treat chest pain and to help patients to stay survival after they have a heart attack. It’s chemical structure sometimes called a benzene acetamide. It is known as a cardio-selective drug and beta1-selective medication too. Scientists have proven in long term investigations for five years that oral administration of atenolol has no effect on hemodynamic. In addition to its role in the medical field, may also introduce several industrial fields, such as water treatment, and also complications with transitional metals. | ||
| Keywords | ||
| atenolol; high blood pressure; cardio-selective; medication | ||
| References | ||
|
[1] MRC working party. (1992). Medical research council trial of treatment of hypertension in older adults. Principal results BMJ, Vol. 304, no. 6824, pp.405-412.
[2] Wander G.S., Chhabra S.T. and Kaur K. (2009). Atenolol drug profile. JAPI Supplement: Journal of Association of Physicians of India, Vol. 57, pp. 13-16.
[3] Lund Johansen, P. (1976). Hemodynamic long-term effects of a new b-adrenoceptor blocking drug, Atenolol (ICI66082), in essential hypertension. Br J Clin Pharmacol, Vol. 3, no. 3, pp. 445-451.
[4] Mikhailidis D. P., Khan M.A., Milionis H. J. and Morgan R. J. (2001) The Treatment of Hypertension in Patients with Erectile Dysfunction. Current Medical Research and Opinion, Vol.16, pp.31-36.
[5] Brown H.C., Carruthers S. G. and Johnson G. D.et al (1976): Clinical pharmacologic observations on atenolol, a beta adrenoceptor blocker. Clin pharmacol Ther., Vol.20, no .5, pp. 34-524.
[6] Sullivan J. M. (1996). Atenolol; Cardiovascular Drug therapy. 2nd edition, pp 48-540.
[7] Astrom H .and Vallin H. (1977) Effect of atenolol on exercise haemodynamics in angina pectoris and hyper tension. Post grad Med J., Vol. 53, pp.3- 84.
[8] Duprez D.A., Florea N., Duval S. and Cohn J. N. (2018). Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the Evidence study. J Hum Hypertens ,Vol.32, pp. 20–25.
[9] Thomas T. and Dooley T. P .(2018). Treatment of Anxiety Prior to a Medical Procedure using an Atenolol - Scopolamine Combination Drug, J Depress Anxiety, Vol. 7, pp. 1-5.
[10] Lindholm L. H., Carlberg B. and Samuelsson O. (2005). Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet (London, England), Vol. 366, no. 9496, pp. 1545–1553.
[11] Vincent H. H., Boomsma F., Man in't Veld A. J., Derkx F. H., Wenting G. J. and Schalekamp M. A. (1984). Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. Journal of cardiovascular pharmacology, Vol. 6, no. 1, pp. 107–114.
[12] Ra J., Yoom H., Son H., Hwang T. and Lee Y. (2019). Transformation of an Amine Moiety of Atenolol during Water Treatment with Chlorine/UV: Reaction Kinetics, Products, and Mechanisms, Environ. Sci. Technol., Vol. 53, pp.7653−7662.
[13] Remucal C. K. and Manley D. (2016). Emerging investigators series: the efficacy of chlorine photolysis as an advanced oxidation process for drinking water treatment. Environmental Science: Water Research &Technology, Vol. 2, no. 4, pp. 565−579.
[14] Watts M. J. and Linden K. G. (2007). Chlorine photolysis and subsequent OH radical production during UV treatment of chlorinated water. Water research, Vol. 41, no. 13, pp. 2871–2878.
[15] Sedaghat S. (2014). Synthesis and Modification of Carboxylated Multi Wall Nanotubes with Atenolol. Soft Nanoscience Letters, Vol. 4, no.3, pp. 75-81.
[16] Tahermansouri H., Chobforosh , D. and Meskinfam, M. (2010). Functionalization of Carboxylated Multi-Wall Nanotubes with 1,2-phenylenediamine. International Journal of Nano Dimension, Vol. 1, pp. 153-159.
[17] Kalita G., Adhikari S., Aryal H. R., Afre R., Soga T., Sharon M. and Umeno M. (2009). Functionalization of Multi-Walled Carbon Nanotubes (MWCNTs) with Nitrogen Plasma for Photovoltaic Device Application. Current Applied Physics, Vol.9, no. 2, pp. 346-351. | ||
|
Statistics Article View: 497 PDF Download: 396 |
||